Vasileiou, S., Hill, L., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B. J., Heslop, H. E., Rooney, C. M., Brenner, M. K., Eagar, T. N., Carrum, G., Grimes, K. A., Leen, A. M. and Lulla, P. (2022) “Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high risk patients”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2022.281946.